medigraphic.com
ISSN 0016-3813 (Print)

2008, Number 4

<< Back Next >>

Gac Med Mex 2008; 144 (4)

Riesgo cardiovascular en adultos con síndrome de apnea obstructiva del sueño. A 25 años de los primeros estudios de asociación

Torre-Bouscoulet L, Meza-Vargas MS, Castorena-Maldonado A, Pérez-Padilla R

Language: Spanish
References: 161
Page: 323-332
PDF size: 81.48 Kb.


ABSTRACT

Cardiovascular diseases and sleep-disordered breathing have been recognized as a public health problem in Mexico and worldwide. These two groups of disorders are closely associated and the evidence accumulated over the last 25 years indicates that obstructive sleep apnea syndrome (OSAS) is an independent risk factor in systemic arterial hypertension, coronary artery disease and stroke. Other associations have also been described, linking these disorders with pulmonary hypertension, cardiac arrhythmias, sudden death during sleep and congestive heart failure. Treatment with continuous positive airway pressure in patients with OSAS has proven to be an efficient primary and secondary cardiovascular prevention strategy. This article reviews the epidemiological evidence that links OSAS with increased cardiovascular risk, and proposes strategies designed to address this growing health problem.


REFERENCES

  1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-689.

  2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badret S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.

  3. Flemons WW. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002;347:498-504.

  4. Young T, Peppard P. Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep 2000;23 Suppl 4:S122-S126.

  5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384.

  6. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community- based study. Sleep Heart Health Study. JAMA 2000;283: 1829-1836.

  7. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-2041.

  8. Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-851.

  9. Lindberg E, Carter N, Gislason T, et al. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001;164:2031-2035.

  10. Torre-Bouscoulet L, Castorena-Maldonado A, Meza-Vargas MS. Otras consecuencias de los trastornos del dormir. A propósito de los accidentes vehiculares. Rev Inst Nal Enf Resp Mex 2005;18:162-169.

  11. Baldwin CM, Griffith KA, Nieto FJ, et al. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001;24:96-105.

  12. Goncalves MA, Paiva T, Ramos E, et al. Obstructive sleep apnea syndrome, sleepiness, and quality of life. Chest 2004;125:2091-2096.

  13. Olson LG, King MT, Hensley MJ, et al. A community study of snoring and sleep-disordered breathing. Prevalence. Am J Respir Crit Care Med 1995;152:711-716.

  14. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001;163:685-689.

  15. Sharma SK, Kumpawat S, Banga A, et al. Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India. Chest 2006;130:149-156.

  16. Kim J, In K, Kim J, et al. Prevalence of sleep-disordered breathing in middleaged Korean men and women. Am J Respir Crit Care Med 2004;170:1108-1113.

  17. Torre-Bouscoulet L, Chávez E, Meza MS, Vázquez JC, Franco F, Muino A, Márquez M, López MV, Valdivia G, Lisboa C, Pertuze J, Jorquera J, Menezes AM. Snoring and sleep-related symptoms in three Latin-American cities. Proc Am Thorac Soc 2005;2:A767.

  18. Rapoport DM, Garay SM, Goldring RM. Nasal CPAP in obstructive sleep apnea: mechanisms of action. Bull Eur Physiopathol Respir 1983;19:616-620.

  19. Leech JA, Onal E, Lopata M. Nasal CPAP continues to improve sleepdisordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. Chest 1992;102:1651-1655.

  20. Findley L, Smith C, Hooper J, et al. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 2000;161:857-859

  21. Montserrat JM, Ferrer M, Hernández L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001;164:608-613.

  22. Kawahara S, Akashiba T, Akahoshi T, et al. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 2005;44:422-427.

  23. Marti S, Sampol G, Muñoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002;20:1511-1518.

  24. Marín JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053.

  25. Gay P, Weaver T, Loube D, et al. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006;29:381-401.

  26. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-1239.

  27. Mexico’s mortality statistics. Deaths registered in 2003. Salud Pública Mex 2005;47:171-187.

  28. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando- Hernández S, Hernández-Ávila M, Sepúlveda-Amor J. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, Morelos: Instituto Nacional de Salud Pública; 2006.

  29. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005;111:614-621.

  30. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289-2295.

  31. Mooe T, Franklin KA, Wiklund U, et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 2000;117:1597-1602.

  32. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006;28:596-602.

  33. Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172:1447-1451.

  34. Atwood CW, Jr., McCrory D, Garcia JG, et al. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest 2004;126:72S-77S.

  35. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-916.

  36. Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206-1214.

  37. Bradley TD, Floras JS. Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 2003;107:1671-1678.

  38. Iber C, Ancoli-Israel S, Chesson A, Quan SF, The American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events. Rules, terminology and technical specifications. Westchester, Illinois: American Academy of Sleep Medicine; 2007.

  39. Phillipson EA. Control of breathing during sleep. Am Rev Respir Dis 1978;118: 909-939.

  40. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147-2165.

  41. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-178.

  42. Caples SM, García-Touchard A, Somers VK. Sleep-disordered breathing and cardiovascular risk. Sleep 2007;30:291-303.

  43. El Solh AA, Akinnusi ME, Baddoura FH, et al. Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 2007;175:1186-1191.

  44. Williams A, Scharf SM. Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF-kappaB the key? Sleep Breath 2007.

  45. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003;42:1067-1074.

  46. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003;290:1906-1914.

  47. Lugaresi E, Cirignotta F, Coccagna G, et al. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980;3:221-224.

  48. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990;97:27-32.

  49. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984;108:373-376.

  50. Fletcher EC, DeBehnke RD, Lovoi MS, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985;103:190-195.

  51. Williams AJ, Houston D, Finberg S, et al. Sleep apnea syndrome and essential hypertension. Am J Cardiol 1985;55:1019-1022.

  52. Hoffstein V, Chan CK, Slutsky AS. Sleep apnea and systemic hypertension: a causal association review. Am J Med 1991;91:190-196.

  53. Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:736-740.

  54. Young T, Peppard P, Palta M, et al. Population-based study of sleepdisordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-1752

  55. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-482.

  56. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159-165.

  57. Pankow W, Lies A, Lohmann FW. Sleep-disordered breathing and hypertension. N Engl J Med 2000;343:966;author reply 967.

  58. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-148.

  59. Giles TL, Lasserson TJ, Smith BH, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006;3:CD001106.

  60. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006;47:840-845.

  61. Hui DS, To KW, Ko FW, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 2006;61:1083-1090.

  62. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001;134:1015-1023.

  63. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006;27:1229-1235.

  64. Martínez-García MA, Gómez-Aldaravi R, Soler-Cataluña JJ, et al. Positive effect of cpap treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007;29:951-957.

  65. Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003;21:241-247.

  66. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-210.

  67. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebocontrolled randomized trials. Arch Intern Med 2007;167:757-764.

  68. Montserrat JM, García-Río F, Barbe F. Diagnostic and therapeutic approach to non-sleepy apnea. Am J Respir Crit Care Med 2007.

  69. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.

  70. Baltzan MA, Kassissia I, Elkholi O, et al. Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure. Sleep 2006;29:557-563

  71. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.

  72. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-734.

  73. Beecroft J, Zanon S, Lukic D, et al. Oral continuous positive airway pressure for sleep apnea: effectiveness, patient preference, and adherence. Chest 2003;124:2200-2208.

  74. Lindberg E, Berne C, Elmasry A, et al. CPAP treatment of a population-based sample—what are the benefits and the treatment compliance? Sleep Med 2006;7:553-560.

  75. Sampol G, Rodes G, Romero O, et al. Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness. Respir Med 2007;101:461-466.

  76. Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-86.

  77. Mooe T, Franklin KA, Holmstrom K, et al. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001;164:1910-1913.

  78. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 1996;101:251-256.

  79. Yumino D, Tsurumi Y, Takagi A, et al. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007;99:26-30.

  80. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004;3:333-342.

  81. Neau JP, Paquereau J, Meurice JC, et al. Stroke and sleep apnoea: cause or consequence? Sleep Med Rev 2002;6:457-469.

  82. Muñoz R, Durán-Cantolla J, Martínez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006;37:2317-2321.

  83. Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:613-618.

  84. Nachtmann A, Stang A, Wang YM, et al. Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients. Atherosclerosis 2003;169:301-307

  85. Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol 2006;13:198-200.

  86. Sandberg O, Franklin KA, Bucht G, et al. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J 2001;18:630-634.

  87. Hsu CY, Vennelle M, Li HY, et al. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006;77:1143-1149.

  88. Martínez-García MA, Galiano-Blancart R, Román-Sánchez P, et al. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005;128:2123-2129.

  89. Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006;37:967-972.

  90. Turkington PM, Allgar V, Bamford J, et al. Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax 2004;59:367-371.

  91. Dziewas R, Humpert M, Hopmann B, et al. Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol 2005;252:1394-1398.

  92. Cadilhac DA, Thorpe RD, Pearce DC, et al. Sleep disordered breathing in chronic stroke survivors. A study of the long term follow-up of the SCOPES cohort using home based polysomnography. J Clin Neurosci 2005;12:632-637.

  93. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:375-380.

  94. White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005;172:1363-1370.

  95. Hui DS, Choy DK, Wong LK, et al. Prevalence of sleep-disordered breathing and continuous positive airway pressure compliance: results in Chinese patients with first-ever ischemic stroke. Chest 2002;122:852-860.

  96. Elwood P, Hack M, Pickering J, et al. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006;60:69-73.

  97. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-494.

  98. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis 1993;148:618-621.

  99. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994;106:466-471.

  100. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589-2594.

  101. Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000;118:591-595.

  102. Ryan CM, Usui K, Floras JS, et al. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005;60:781-785.

  103. Mitchell AR, Spurrell PA, Sulke N. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. Am Heart J 2003;146:902-907.

  104. Yamakawa H, Shiomi T, Sasanabe R, et al. Pulmonary hypertension in patients with severe obstructive sleep apnea. Psychiatry Clin Neurosci 2002;56:311-312.

  105. Bady E, Achkar A, Pascal S, et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 2000;55:934-939.

  106. Sanner BM, Doberauer C, Konermann M, et al. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 1997;157:2483-2487.

  107. Schafer H, Hasper E, Ewig S, et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998;12:679-684.

  108. Weitzenblum E, Chaouat A. Obstructive sleep apnea syndrome and the pulmonary circulation. Ital Heart J 2005;6:795-798.

  109. Zielinski J. Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans. Eur Respir J 2005;25:173-180.

  110. Guidry UC, Mendes LA, Evans JC, et al. Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am J Respir Crit Care Med 2001;164:933-938.

  111. Krieger J, Sforza E, Apprill M, et al. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest 1989;96:729-737.

  112. Weitzenblum E, Krieger J, Apprill M, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138:345-349.

  113. Niijima M, Kimura H, Edo H, et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1999;159:1766-1772.

  114. Alchanatis M, Tourkohoriti G, Kakouros S, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001;68:566-572.

  115. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:152-158.

  116. Eckert DJ, Jordan AS, Merchia P, et al. Central sleep apnea: pathophysiology and treatment. Chest 2007;131:595-607.

  117. Tkacova R, Wang H, Bradley TD. Night-to-night alterations in sleep apnea type in patients with heart failure. J Sleep Res 2006;15:321-328.

  118. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625-1631.

  119. Ryan CM, Bradley TD. Periodicity of obstructive sleep apnea in patients with and without heart failure. Chest 2005;127:536-542.

  120. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-2033.

  121. Arzt M, Young T, Finn L, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006;166:1716-1722.

  122. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-1241.

  123. Sin DD, Fitzgerald F, Parker JD, et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003;123:1536- 1543.

  124. Arzt M, Bradley TD. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006;173:1300-1308.

  125. Yoshinaga K, Burwash IG, Leech JA, et al. The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 2007;49:450-458.

  126. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000;102:61-66.

  127. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004;43:317-327.

  128. Arias MA, García-Río F, Alonso-Fernández A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005;112:375-383.

  129. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497

  130. Wolk R, Somers VK. Sleep and the metabolic syndrome. Exp Physiol 2007;92:67-78

  131. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002;162:893-900.

  132. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291:2013-2016.

  133. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677-682.

  134. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-741.

  135. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-676.

  136. McArdle N, Hillman D, Beilin L, et al. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007;175:190-195.

  137. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521-530.

  138. Punjabi NM, Ahmed MM, Polotsky VY, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003;136:167-178.

  139. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004;169:1231-1237.

  140. Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172:1590-1595.

  141. Sharma SK, Kumpawat S, Goel A, et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleepdisordered breathing. Sleep Med 2007;8:12-17.

  142. Sasanabe R, Banno K, Otake K, et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 2006;29:315- 322.

  143. Waters KA, Sitha S, O’Brien L M, et al. Follow-up on metabolic markers in children treated for obstructive sleep apnea. Am J Respir Crit Care Med 2006;174:455-460.

  144. Lam JC, Lam B, Lam CL, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med 2006;100:980-987.

  145. Ambrosetti M, Lucioni AM, Conti S, et al. Metabolic syndrome in obstructive sleep apnea and related cardiovascular risk. J Cardiovasc Med 2006;7:826-829.

  146. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004;71:252-259.

  147. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-162.

  148. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-452.

  149. Newman AB, Foster G, Givelber R, et al. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005;165:2408-2413.

  150. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005;9:211-224.

  151. Onat A, Hergenc G, Uyarel H, et al. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance. Sleep Breath 2007;11:23-30.

  152. Kim HC, Young T, Matthews CG, et al. Sleep-disordered breathing and neuropsychological deficits. A population-based study. Am J Respir Crit Care Med 1997;156:1813-1819.

  153. Peppard PE, Szklo-Coxe M, Hla KM, et al. Longitudinal association of sleeprelated breathing disorder and depression. Arch Intern Med 2006;166:1709-1715.

  154. Engleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004;59:618-622.

  155. Ryan CF. Sleep x 9: an approach to treatment of obstructive sleep apnoea/ hypopnoea syndrome including upper airway surgery. Thorax 2005;60:595-604.

  156. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499-521.

  157. Flemons WW, Douglas NJ, Kuna ST, et al. Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med 2004;169:668-672.

  158. Flemons WW, Littner MR, Rowley JA, et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003;124:1543-1579.

  159. Ayas NT, FitzGerald JM, Fleetham JA, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006;166:977-984.

  160. Torre Bouscoulet L, López-Escárcega E, Castorena-Maldonado A, et al. Continuous positive airway pressure used by adults with obstructive sleep apneas after prescription in a public referral hospital in Mexico City. Arch Bronconeumol 2007;43:16-21.

  161. Cross MD, Vennelle M, Engleman HM, et al. Comparison of CPAP titration at home or the sleep laboratory in the sleep apnea hypopnea syndrome. Sleep 2006;29:1451-1455.




2020     |     www.medigraphic.com